These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9276020)

  • 1. Synthesis and anti-hepatitis B virus activity of 9-(2-deoxy-2-fluoro-beta-L-arabinofuranosyl) purine nucleosides.
    Ma T; Lin JS; Newton MG; Cheng YC; Chu CK
    J Med Chem; 1997 Aug; 40(17):2750-4. PubMed ID: 9276020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure--activity relationships of 1-(2-Deoxy-2-fluoro-beta-L-arabinofuranosyl)pyrimidine nucleosides as anti-hepatitis B virus agents.
    Ma T; Pai SB; Zhu YL; Lin JS; Shanmuganathan K; Du J; Wang C; Kim H; Newton MG; Cheng YC; Chu CK
    J Med Chem; 1996 Jul; 39(14):2835-43. PubMed ID: 8709113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleosides. 146. 1-Methyl-5-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)uracil, the C-nucleoside isostere of the potent antiviral agent 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)thymine (FMAU). Studies directed toward the synthesis of 2'-deoxy-2'-substituted arabino nucleosides. 6.
    Pankiewicz KW; Nawrot B; Gadler H; Price RW; Watanabe KA
    J Med Chem; 1987 Dec; 30(12):2314-6. PubMed ID: 2824777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of hepatitis B virus by a novel L-nucleoside, 2'-fluoro-5-methyl-beta-L-arabinofuranosyl uracil.
    Balakrishna Pai S; Liu SH; Zhu YL; Chu CK; Cheng YC
    Antimicrob Agents Chemother; 1996 Feb; 40(2):380-6. PubMed ID: 8834884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical investigation of L-FMAU as an anti-hepatitis B virus agent.
    Chu CK; Boudinot FD; Peek SF; Hong JH; Choi Y; Korba BE; Gerin JL; Cote PJ; Tennant BC; Cheng YC
    Antivir Ther; 1998; 3(Suppl 3):113-21. PubMed ID: 10726061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleosides. 150. Synthesis and some biological properties of 5-monofluoromethyl, 5-difluoromethyl, and 5-trifluoromethyl derivatives of 2'-deoxyuridine and 2'-deoxy-2'-fluoro-beta-D-arabinofuranosyluracil.
    Matulic-Adamic J; Takahashi K; Chou TC; Gadler H; Price RW; Reddy AR; Kalman TI; Watanabe KA
    J Med Chem; 1988 Aug; 31(8):1642-7. PubMed ID: 2840503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil as a novel antiviral agent for hepatitis B virus and Epstein-Barr virus.
    Chu CK; Ma T; Shanmuganathan K; Wang C; Xiang Y; Pai SB; Yao GQ; Sommadossi JP; Cheng YC
    Antimicrob Agents Chemother; 1995 Apr; 39(4):979-81. PubMed ID: 7786007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and anti-DNA viral activities in vitro of certain 2,4-disubstituted-7-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)pyrrolo[2,3-d d pyrimidine nucleosides.
    Bhattacharya BK; Ojwang JO; Rando RF; Huffman JH; Revankar GR
    J Med Chem; 1995 Sep; 38(20):3957-66. PubMed ID: 7562929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibilities of wild-type or drug-resistant hepatitis B virus to (-)-beta-D-2,6-diaminopurine dioxolane and 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil.
    Chin R; Shaw T; Torresi J; Sozzi V; Trautwein C; Bock T; Manns M; Isom H; Furman P; Locarnini S
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2495-501. PubMed ID: 11502520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral activity of various 1-(2'-deoxy-β-D-lyxofuranosyl), 1-(2'-fluoro-β-D-xylofuranosyl), 1-(3'-fluoro-β-D-arabinofuranosyl), and 2'-fluoro-2',3'-didehydro-2',3'-dideoxyribose pyrimidine nucleoside analogues against duck hepatitis B virus (DHBV) and human hepatitis B virus (HBV) replication.
    Srivastav NC; Shakya N; Mak M; Agrawal B; Tyrrell DL; Kumar R
    J Med Chem; 2010 Oct; 53(19):7156-66. PubMed ID: 20857959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and biological evaluation of novel 2'-deoxy-2'-fluoro-2'-C-methyl 8-azanebularine derivatives as potent anti-HBV agents.
    Yang W; Peng Y; Wang J; Song C; Yu W; Zhou Y; Jiang J; Wang Q; Wu J; Chang J
    Bioorg Med Chem Lett; 2019 Jun; 29(11):1291-1297. PubMed ID: 30962085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of 2',3'-dideoxy-L-pyrimidine nucleosides as potential antiviral agents against human immunodeficiency virus (HIV) and hepatitis B virus (HBV).
    Lin TS; Luo MZ; Liu MC; Pai SB; Dutschman GE; Cheng YC
    J Med Chem; 1994 Mar; 37(6):798-803. PubMed ID: 8145230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and biological evaluation of new 1,2,3-triazolo-2'-deoxy-2'-fluoro- 4'-azido nucleoside derivatives as potent anti-HBV agents.
    Liu Y; Peng Y; Lu J; Wang J; Ma H; Song C; Liu B; Qiao Y; Yu W; Wu J; Chang J
    Eur J Med Chem; 2018 Jan; 143():137-149. PubMed ID: 29174810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in vitro anti-hepatitis B virus activity of FIAU [1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl-5-iodo)uracil] is selective, reversible, and determined, at least in part, by the host cell.
    Staschke KA; Colacino JM; Mabry TE; Jones CD
    Antiviral Res; 1994 Jan; 23(1):45-61. PubMed ID: 8141592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleosides. 139. Synthesis and anticytomegalovirus and antiherpes simplex virus activity of 5'-modified analogues of 2'-fluoroarabinosylpyrimidine nucleosides.
    Harada K; Matulic-Adamic J; Price RW; Schinazi RF; Watanabe KA; Fox JJ
    J Med Chem; 1987 Jan; 30(1):226-9. PubMed ID: 3027334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A practical synthesis of L-FMAU from L-arabinose.
    Du J; Choi Y; Lee K; Chun BK; Hong JH; Chu CK
    Nucleosides Nucleotides; 1999 Feb; 18(2):187-95. PubMed ID: 10067271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological evaluation of new N(4)-Substituted 2'-deoxy-2'-fluoro-4'-azido cytidine derivatives as potent anti-HBV agents.
    Lv Z; He W; Tian X; Kang J; Liu Y; Peng Y; Zheng L; Wang Q; Yu W; Chang J
    Eur J Med Chem; 2015 Aug; 101():103-10. PubMed ID: 26119991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of 2'-deoxy-2'-[18F]fluoro-beta-D-arabinofuranosyl nucleosides, [18F]FAU, [18F]FMAU, [18F]FBAU and [18F]FIAU, as potential PET agents for imaging cellular proliferation. Synthesis of [18F]labelled FAU, FMAU, FBAU, FIAU.
    Mangner TJ; Klecker RW; Anderson L; Shields AF
    Nucl Med Biol; 2003 Apr; 30(3):215-24. PubMed ID: 12745012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the unique mechanism of L-FMAU (clevudine) against hepatitis B virus: molecular dynamics studies.
    Chong Y; Chu CK
    Bioorg Med Chem Lett; 2002 Dec; 12(23):3459-62. PubMed ID: 12419383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleosides. 129. Synthesis of antiviral nucleosides: 5-alkenyl-1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)uracils.
    Watanabe KA; Su TL; Reichman U; Greenberg N; Lopez C; Fox JJ
    J Med Chem; 1984 Jan; 27(1):91-4. PubMed ID: 6317862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.